HeartWare names Peter F. McAree as CFO

Monday, July 9, 2012 04:48 PM

HeartWare International, a developer of less invasive, miniaturized circulatory support technologies for treatment of advanced heart failure, has appointed Peter F. McAree as senior vice president, CFO and Treasurer

McAree brings more than 25 years of financial management and public accounting experience to HeartWare International. He most recently served as senior vice president and CFO at Caliper Life Sciences, prior to the company's acquisition by PerkinElmer in November, 2011. McAree also served as CFO of Zymark prior to the company's merger with Caliper in 2003. 

Outside the pharmaceutical and medical device industry, McAree has served in many financial leadership positions, including Arthur Andersen and Enterprise Group.

Share:          
CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs